Filing Details
- Accession Number:
- 0001181431-12-045770
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-15 16:30:38
- Reporting Period:
- 2012-08-13
- Filing Date:
- 2012-08-15
- Accepted Time:
- 2012-08-15 16:30:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seattle Genetics Inc | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1202785 | Eric Dobmeier | 21823 30Th Drive Se Bothell WA 98021 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-08-13 | 25,000 | $24.01 | 43,352 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Eric Dobmeier on March 5, 2012.
- $24.011582 represents an average price per share for the shares sold on 8/13/12. The sell price for shares sold on this day ranged from $23.78 to $24.32.
- Amount of securities beneficially owned following reported transactions includes 25,220 Restricted Stock Units subject to vesting.
Billionaire Hedge Funds
